Co-delivery of autophagy inhibitor and gemcitabine using a pH-activatable core-shell nanobomb inhibits pancreatic cancer progression and metastasis
Xiaoxiao Chen(Chinese Academy of Sciences), Qin He(Central China Normal University), Tao Yuan(Sichuan University), Xuan He(Xinjiang Medical University), Manmin He(Sichuan University), Kebai Ren(Sichuan University), Ting Li(Fujian University of Traditional Chinese Medicine), Zhirong Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xuhui Wang(Sichuan University), Rong Guo(Sichuan University), Man Li(Sichuan University), Miao Deng(Sichuan University), Shuya Zang(Sichuan University), Qinglin Sheng(Sichuan University)
Cited by 46
Related Papers
T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
|Journal of Biological Chemistry|2014|249
Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening
|Biomedicine & Pharmacotherapy|2019|200
Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals
|Cancer Medicine|2019|197
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
|Journal of Controlled Release|2019|126
Tumor-Associated Fibroblast-Targeted Regulation and Deep Tumor Delivery of Chemotherapeutic Drugs with a Multifunctional Size-Switchable Nanoparticle
|ACS Applied Materials & Interfaces|2019|98